CRISPR Therapeutics AG CRSP
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.88% | -3.17% | 23.58% | 3.14% | 11.30% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 73.18% | 13.62% | 3.76% | -39.76% | 10.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.75% | 0.00% | -89.72% | 11.14% | 0.00% |
| Total Current Assets | -3.66% | -3.13% | 23.30% | 2.93% | 11.27% |
|
|
|||||
| Total Current Assets | -3.66% | -3.13% | 23.30% | 2.93% | 11.27% |
| Net Property, Plant & Equipment | -2.89% | -2.98% | -2.72% | -3.10% | -2.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.89% | 0.30% | 0.16% | -3.26% | -10.70% |
| Total Assets | -3.56% | -2.75% | 20.33% | 0.89% | 10.62% |
|
|
|||||
| Total Accounts Payable | 82.06% | -17.15% | 22.53% | -5.59% | 20.97% |
| Total Accrued Expenses | -5.16% | 6.02% | -15.95% | 38.38% | -9.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.18% | 0.18% | 0.18% | 1.76% | 1.27% |
| Total Finance Division Other Current Liabilities | 0.47% | -3.77% | -11.63% | 32.72% | 30.05% |
| Total Other Current Liabilities | 0.47% | -3.77% | -11.63% | 32.72% | 30.05% |
| Total Current Liabilities | 6.07% | -2.49% | -8.61% | 25.36% | 13.98% |
|
|
|||||
| Total Current Liabilities | 6.07% | -2.49% | -8.61% | 25.36% | 13.98% |
| Long-Term Debt | 0.13% | 0.12% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.62% | -2.54% | -2.45% | -2.39% | -2.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.23% | 4.59% | -3.16% | -65.10% | 4.77% |
| Total Liabilities | 0.46% | -0.77% | 165.34% | 4.28% | 3.37% |
|
|
|||||
| Common Stock & APIC | 0.57% | 0.66% | 0.58% | 3.66% | 9.08% |
| Retained Earnings | -5.16% | -4.40% | -6.31% | -7.19% | -6.22% |
| Treasury Stock & Other | -201.62% | -134.33% | -142.03% | -3.35% | 23.80% |
| Total Common Equity | -5.64% | -3.75% | -5.58% | 0.30% | 11.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.64% | -3.75% | -5.58% | 0.30% | 11.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.64% | -3.75% | -5.58% | 0.30% | 11.97% |
|
|
|||||